RecruitingNCT07350759

Observational Study Designed to Detect Decompensation of Congestive Heart Failure (dCHF) Using a Non-Invasive Wearable Device

An Observational Study to Develop an Algorithm to Predict Decompensation of Congestive Heart Failure (dCHF) Using a Non-Invasive Wearable Device.


Sponsor

CHFDX,Inc.

Enrollment

60 participants

Start Date

Mar 9, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective, observational pilot study designed to develop a mathematical algorithm capable of predicting decompensation of congestive heart failure (dCHF) using physiologic data collected from a non-invasive wearable device. Participants with a remote hemodynamic pulmonary artery pressure monitor will wear a wearable device continuously for up to 12 months. Wearable data will be analyzed in relation to the hemodynamic monitor defined sentinel events of heart failure decompensation to identify predictive signal patterns. Optional biospecimen (DNA, blood, urine) and voice sample collection will support future biomarker discovery.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • • Age ≥ 18 years
  • Current use of a hemodynamic sensoring device
  • At least 4 consecutive weeks of stabilized "goal" pulmonary artery pressures
  • Access to a personal smartphone with Wi-Fi or cellular connectivity

Exclusion Criteria5

  • • Inability to provide informed consent
  • Inability to read or understand English
  • Likely non-adherence to wearable device use
  • Prisoners
  • Pregnant females

Interventions

DEVICEwearable ring device with multiple embedded sensors to detect heart rate, SVO2, respiratory rate, heart rate variability and a number of other related physiologic parameters

In this observational study, a non-invasive, wearable ring used for continuous passive collection of physiologic data (sleep, activity, heart rate, HRV, temperature) will be used to collect data from all patients in the study. Data are used solely for research and algorithm development and are not used for diagnosis or treatment.


Locations(2)

USF Office of Clinical Research

Tampa, Florida, United States

USF

Tampa, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07350759